Amati investors Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Amati investors

AMTX 1.595

-0.3%

Feb 6 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: pat mudge who wrote (3403)	9/4/1996 1:54:00 PM
From: Techie	of 31386

Pat, I don't think I missed any point. You accused me of spreading rumors and when I told you the source and gave you specifics and asked you questions, you don't reply but go on a tangent. There is hell of a lot more to doing research than listening to the PR of company executives who leak BS and then follow it up with hot-air press releases. Kim Maxwell's comments on where the committee stands is nothing new. We knew they felt that way for a couple of months now. (Read back Dr. Hank Zannini's posts). The direction the vendors and trials are taking is telling us an entirely different story. If Carlini thinks CAP isn't winning this first round, well, he should think again. Nortel holds the patents to DMT for their own use, they never had any products. Now they have decided to implement CAP (at least ahead of DMT). Do you consider this to be good news for DMT? New licensees shows the direction these companies are moving in, unless you think they go and pay for licenses for the fun of it. I asked you to post Amati's opinion on CAP vs DMT because I seriously doubt they would publicly state that DMT is winning this phase. If that's what they really think they are going to have a rude awakening.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next